Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN)

Clinical trial NCT05717621 · COMPLETED

Trial details

NCT number: NCT05717621
Sponsor: ViMREX GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vulvar Intraepithelial Neoplasia Grade 2 Vulvar Intraepithelial Neoplasia Grade 3

Start date: 2023-03-28
Primary completion: 2025-01-17
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.